Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGP-437 Iontophoresis in Cataract Surgery
NCT01602068Phase 2Completed
- Sponsor
- Kiora Pharmaceuticals
- Start
- May 2012
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone phosphate iontophoretic ophthalmic solution in post-operative inflammation, postoperative pain, sponsored by Kiora Pharmaceuticals. Started May 2012; status: completed.
02
Drugs
dexamethasone phosphate iontophoretic ophthalmic solution
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT01602068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602068.